Yazji Salim 4
4 · Oncternal Therapeutics, Inc. · Filed Jan 31, 2022
Insider Transaction Report
Form 4
Yazji Salim
Chief Medical Officer
Transactions
- Purchase
Common Stock
2022-01-27$1.69/sh+10,000$16,900→ 67,137 total
4 · Oncternal Therapeutics, Inc. · Filed Jan 31, 2022
Common Stock